Talhera, Inc. Faces Delisting Notice

TL;DR

Talhera's stock is at risk of being delisted.

AI Summary

Talhera, Inc. (formerly AcelRx Pharmaceuticals Inc.) filed an 8-K on November 29, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The filing indicates a significant event related to the company's stock exchange status as of November 27, 2024.

Why It Matters

This filing signals potential issues with Talhera's continued listing on a stock exchange, which could impact its stock price and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards indicates significant financial or operational distress for the company.

Key Players & Entities

• Talhera, Inc. (company) — Registrant
• AcelRx Pharmaceuticals Inc. (company) — Former company name
• November 27, 2024 (date) — Date of earliest event reported
• November 29, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value TLPH The Nasdaq Global Ma
• $9,641,000 — n the Company's stockholders' equity of $9,641,000 as of September 30, 2024, as reported i
• $10,000,000 — intain stockholders' equity of at least $10,000,000 or meet the alternative compliance stan

Filing Documents

• acrx20241129_8k.htm (8-K) — 26KB
• 0001437749-24-036376.txt ( ) — 155KB
• tlph-20241127.xsd (EX-101.SCH) — 3KB
• tlph-20241127_def.xml (EX-101.DEF) — 11KB
• tlph-20241127_lab.xml (EX-101.LAB) — 15KB
• tlph-20241127_pre.xml (EX-101.PRE) — 11KB
• acrx20241129_8k_htm.xml (XML) — 3KB

01

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 27, 2024, Talphera, Inc. (the "Company") received a written notice from the Listing Qualifications Staff of the Nasdaq Stock Market ("Nasdaq") notifying the Company that, based on the Company's stockholders' equity of $9,641,000 as of September 30, 2024, as reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, the Company is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(1)(A), which requires companies to maintain stockholders' equity of at least $10,000,000 or meet the alternative compliance standards relating to the market value of the listed securities or the Company's total assets and revenue (the "Notice"). This Notice has no immediate effect on the listing of the Company's stock on the Nasdaq Global Market. As stated in the Notice, the Company has until January 13, 2025 to provide Nasdaq with a plan to achieve and sustain compliance with the Minimum Stockholder Equity Requirement (the "Compliance Plan"). If Nasdaq accepts the Compliance Plan, Nasdaq may grant an extension of up to 180 calendar days from the date of the Notice to evidence compliance with the Minimum Stockholder Equity Requirement. If Nasdaq does not accept the Compliance Plan, then the Nasdaq staff will provide written notification to the Company that its common stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel, which would stay all further actions. The Company intends to submit the Compliance Plan to Nasdaq, within the required time period. There can be no assurance that Nasdaq will accept the Compliance Plan, the Company will be able to regain compliance with Listing Rule 5550(b)(1) or maintain compliance with any other Nasdaq requirement

Forward-Looking Statements

Forward-Looking Statements Certain of the statements made in this report are forward-looking, such as those, among others, relating to the Company's ability to regain compliance with the Minimum Stockholder Equity Requirement and the Company's intentions to submit a Compliance Plan to Nasdaq within the require time period. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. More information about the risks and uncertainties faced by the Company is contained under the caption "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the SEC on November 13, 2024. You are cautioned not to place undue reliance on forward-looking statements which are current only as of the date hereof. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 29, 2024 TALPHERA, INC. By: /s/ Raffi Asadorian Raffi Asadorian Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR